Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Medtronic plc    MDT   IE00BTN1Y115

MEDTRONIC PLC

(MDT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Medtronic : 4Q Profit, Sales Fall as Medical Procedures Delayed Amid Pandemic

share with twitter share with LinkedIn share with facebook
05/21/2020 | 07:20am EDT

By Dave Sebastian

 

Medtronic PLC said its profit and sales for the fiscal fourth quarter fell as medical procedures were delayed due to the Covid-19 pandemic.

The medical-technology company on Thursday posted net income of $646 million, or 48 cents a share, compared with $1.17 billion, or 87 cents a share, in the comparable quarter last year.

Adjusted earnings were 58 cents a share, below the 96 cents a share analysts polled by FactSet had expected.

Revenue fell 26% to $6 billion from the year-ago period. Analysts were looking for $6.93 billion.

The company also raised its dividend to 58 cents a share for the first quarter. That translates into $2.32 a share per year, up from $2.16.

Medtronic said it isn't providing financial guidance due to the pandemic.

 

Write to Dave Sebastian at dave.sebastian@wsj.com

 

Stocks mentioned in the article
ChangeLast1st jan.
MEDTRONIC PLC 0.91% 93.16 Delayed Quote.-17.88%
THE NEW HOME COMPANY INC. 0.63% 3.2 Delayed Quote.-31.33%
share with twitter share with LinkedIn share with facebook
Latest news on MEDTRONIC PLC
07/01MEDTRONIC : A Conversation and Question & Answer Session with Rebecca Seidel, VP..
PU
06/26MEDTRONIC : FDA Approves First-Of-Its-Kind Percept PC Neurostimulator with Brain..
AQ
06/25MEDTRONIC : Says Data Show Renal Denervation Lowered Blood Pressure in Patients ..
DJ
06/25MEDTRONIC : Canada Named to the 2020 List of Best Workplaces in Ontario
AQ
06/25New Real-World Data from Medtronic Global SYMPLICITY Registry Show Renal Dene..
GL
06/25MEDTRONIC : Gets FDA OK for Percept PC Deep Brain Stimulation System
DJ
06/25MEDTRONIC : FDA Approves First-Of-Its-Kind Percept™ PC Neurostimulator wit..
AQ
06/25MEDTRONIC PLC : Ex-dividend day for
FA
06/22Medtronic Evolut TAVI System Receives Expanded Indication in Europe to Treat ..
GL
06/19MEDTRONIC : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
More news
Financials (USD)
Sales 2021 27 831 M - -
Net income 2021 3 338 M - -
Net Debt 2021 18 181 M - -
P/E ratio 2021 37,1x
Yield 2021 2,41%
Capitalization 125 B 125 B -
EV / Sales 2020
EV / Sales 2021 5,14x
Nbr of Employees 104 950
Free-Float 99,9%
Chart MEDTRONIC PLC
Duration : Period :
Medtronic plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDTRONIC PLC
Short TermMid-TermLong Term
TrendsBearishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 28
Average target price 111,52 $
Last Close Price 93,16 $
Spread / Highest target 39,5%
Spread / Average Target 19,7%
Spread / Lowest Target -3,39%
EPS Revisions
Managers
NameTitle
Geoffrey Straub Martha President, Chief Executive Officer & Director
Omar S. Ishrak Executive Chairman
Mark Ploof Senior VP-Global Operations & Business Services
Karen L. Parkhill Chief Financial & Accounting Officer, Executive VP
Richard E. Kuntz Chief Scientific, Clinical & Regulatory Officer
Sector and Competitors
1st jan.Capitalization (M$)
MEDTRONIC PLC-17.88%124 955
BAXTER INTERNATIONAL INC.4.29%44 376
DEXCOM, INC.86.23%37 617
HOYA CORPORATION0.57%35 259
TERUMO CORPORATION5.74%28 523
ZIMMER BIOMET HOLDINGS-19.42%24 942